Immunotherapy for Lung Cancer

Dr. Julie Brahmer, Johns Hopkins University, discusses immunotherapies for NSCLC and SCLC, analyzes the relevant trial data and addresses the unique side effects of these therapies.
cancergrace.org/cancer-treatme...

[@russelmiller7311]

That's a great analysis on the previously available immunotherapies. Immune checkpoints have been targeted for quite a while and new progress has been in recent one year after the vedio has been posted.

[@sevilbhn2157]

Very nice thanks for novel idea